Cencora (COR) Stock Forecast: StockMap's 2-Week Call
COR stock forecast: StockMap's model leans Outperform on Cencora for the two weeks after the Nov 13 close, toward COR doing better than the growth index. It is a lean inside the no-call band, not a call, and not a price target. Right in 2 of 3 two-week windows on COR since Sep 28; by chance, a call on the same dates was right 67% of the time.
Cencora last closed at $359.03, +2.76% on the session.
Against the IVW growth benchmark the position is +3.67% over the forecast window.
Cencora's market cap is $68.51B as of November 13, 2026, #187 in the S&P 500.
Leans up ↗: a small lean, not a call · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is 30 (too close to call).
Where COR sits: sized by market cap, coloured by the day's move.
The read is built from 15 underlying insights — 9 bullish and 6 bearish.
Agreement across those insights is 60%.
4 daily calls for COR so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.
On the fundamentals StockMap ranks Cencora in the 48th percentile on valuation and the 96th percentile on return on equity, where 100 is best.
Cencora is classified under Health Care / Health Care Providers & Services.
StockMap tracks Cencora as the 7th largest of the 88 companies it covers in the Health Care Providers & Services industry, part of the Health Care sector.
Across that group the current two-week reads are 53 Neutral, 17 Moderate Outperform, 13 Moderate Underperform, 4 Strong Underperform and 1 Strong Outperform.
On that composite Cencora ranks 8th of 88 in the group, against a group median of +0.01.